Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor

Donald R. Gehlert, Anantha Shekhar, S. Michelle Morin, Phillip A. Hipskind, Charity Zink, Susan L. Gackenheimer, Janice Shaw, Stephanie D. Fitz, Tammy J. Sajdyk

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Corticotropin releasing factor (CRF) and Urocortin are important neurotransmitters in the regulation of physiological and behavioral responses to stress. Centrally administered CRF or Urocortin produces anxiety-like responses in numerous animal models of anxiety disorders. Previous studies in our lab have shown that Urocortin infused into the basolateral nucleus of the amygdala produces anxiety-like responses in the social interaction test. Subsequently, in the current study we prepared a specific CRF1 receptor antagonist (N-Cyclopropylmethyl-2,5-dimethyl-N-propyl-N′-(2,4,6-trichloro-phenyl)- pyrimidine-4,6-diamine, NBI3b1996) to examine in this paradigm. This CRF1 receptor antagonist inhibited the ex vivo binding of 125I-sauvagine to rat cerebellum with an ED50 of 6 mg/kg, i.p. NBI3b1996 produced a dose-dependent antagonism of Urocortin-induced anxiety-like behavior in Social Interaction test with an ED50 of 6 mg/kg, i.p. The compound had no effect on baseline social interaction. In addition, the CRF1 receptor antagonist prevented the stress-induced decrease in social interaction. These results provide further support for the CRF1 receptor in anxiety-like behavior and suggest this pathway is quiescent in unstressed animals.

Original languageEnglish
Pages (from-to)145-153
Number of pages9
JournalEuropean Journal of Pharmacology
Volume509
Issue number2-3
DOIs
StatePublished - Feb 21 2005

Fingerprint

Urocortins
Interpersonal Relations
Anxiety
Corticotropin-Releasing Hormone
Amygdala
Anxiety Disorders
Cerebellum
Neurotransmitter Agents
Animal Models
CRF receptor type 1
N-cyclopropylmethyl-2,5-dimethyl-N-propyl-N'-(2,4,6-trichloro-phenyl)-pyrimidine-4,6-diamine

Keywords

  • (Rat)
  • Amygdala
  • Antagonist
  • Behavior
  • Corticotropin releasing factor
  • Stress

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor. / Gehlert, Donald R.; Shekhar, Anantha; Morin, S. Michelle; Hipskind, Phillip A.; Zink, Charity; Gackenheimer, Susan L.; Shaw, Janice; Fitz, Stephanie D.; Sajdyk, Tammy J.

In: European Journal of Pharmacology, Vol. 509, No. 2-3, 21.02.2005, p. 145-153.

Research output: Contribution to journalArticle

Gehlert, DR, Shekhar, A, Morin, SM, Hipskind, PA, Zink, C, Gackenheimer, SL, Shaw, J, Fitz, SD & Sajdyk, TJ 2005, 'Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor', European Journal of Pharmacology, vol. 509, no. 2-3, pp. 145-153. https://doi.org/10.1016/j.ejphar.2004.12.030
Gehlert, Donald R. ; Shekhar, Anantha ; Morin, S. Michelle ; Hipskind, Phillip A. ; Zink, Charity ; Gackenheimer, Susan L. ; Shaw, Janice ; Fitz, Stephanie D. ; Sajdyk, Tammy J. / Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor. In: European Journal of Pharmacology. 2005 ; Vol. 509, No. 2-3. pp. 145-153.
@article{a067ff40bc724027a57b9b03a03d0594,
title = "Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor",
abstract = "Corticotropin releasing factor (CRF) and Urocortin are important neurotransmitters in the regulation of physiological and behavioral responses to stress. Centrally administered CRF or Urocortin produces anxiety-like responses in numerous animal models of anxiety disorders. Previous studies in our lab have shown that Urocortin infused into the basolateral nucleus of the amygdala produces anxiety-like responses in the social interaction test. Subsequently, in the current study we prepared a specific CRF1 receptor antagonist (N-Cyclopropylmethyl-2,5-dimethyl-N-propyl-N′-(2,4,6-trichloro-phenyl)- pyrimidine-4,6-diamine, NBI3b1996) to examine in this paradigm. This CRF1 receptor antagonist inhibited the ex vivo binding of 125I-sauvagine to rat cerebellum with an ED50 of 6 mg/kg, i.p. NBI3b1996 produced a dose-dependent antagonism of Urocortin-induced anxiety-like behavior in Social Interaction test with an ED50 of 6 mg/kg, i.p. The compound had no effect on baseline social interaction. In addition, the CRF1 receptor antagonist prevented the stress-induced decrease in social interaction. These results provide further support for the CRF1 receptor in anxiety-like behavior and suggest this pathway is quiescent in unstressed animals.",
keywords = "(Rat), Amygdala, Antagonist, Behavior, Corticotropin releasing factor, Stress",
author = "Gehlert, {Donald R.} and Anantha Shekhar and Morin, {S. Michelle} and Hipskind, {Phillip A.} and Charity Zink and Gackenheimer, {Susan L.} and Janice Shaw and Fitz, {Stephanie D.} and Sajdyk, {Tammy J.}",
year = "2005",
month = "2",
day = "21",
doi = "10.1016/j.ejphar.2004.12.030",
language = "English",
volume = "509",
pages = "145--153",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor

AU - Gehlert, Donald R.

AU - Shekhar, Anantha

AU - Morin, S. Michelle

AU - Hipskind, Phillip A.

AU - Zink, Charity

AU - Gackenheimer, Susan L.

AU - Shaw, Janice

AU - Fitz, Stephanie D.

AU - Sajdyk, Tammy J.

PY - 2005/2/21

Y1 - 2005/2/21

N2 - Corticotropin releasing factor (CRF) and Urocortin are important neurotransmitters in the regulation of physiological and behavioral responses to stress. Centrally administered CRF or Urocortin produces anxiety-like responses in numerous animal models of anxiety disorders. Previous studies in our lab have shown that Urocortin infused into the basolateral nucleus of the amygdala produces anxiety-like responses in the social interaction test. Subsequently, in the current study we prepared a specific CRF1 receptor antagonist (N-Cyclopropylmethyl-2,5-dimethyl-N-propyl-N′-(2,4,6-trichloro-phenyl)- pyrimidine-4,6-diamine, NBI3b1996) to examine in this paradigm. This CRF1 receptor antagonist inhibited the ex vivo binding of 125I-sauvagine to rat cerebellum with an ED50 of 6 mg/kg, i.p. NBI3b1996 produced a dose-dependent antagonism of Urocortin-induced anxiety-like behavior in Social Interaction test with an ED50 of 6 mg/kg, i.p. The compound had no effect on baseline social interaction. In addition, the CRF1 receptor antagonist prevented the stress-induced decrease in social interaction. These results provide further support for the CRF1 receptor in anxiety-like behavior and suggest this pathway is quiescent in unstressed animals.

AB - Corticotropin releasing factor (CRF) and Urocortin are important neurotransmitters in the regulation of physiological and behavioral responses to stress. Centrally administered CRF or Urocortin produces anxiety-like responses in numerous animal models of anxiety disorders. Previous studies in our lab have shown that Urocortin infused into the basolateral nucleus of the amygdala produces anxiety-like responses in the social interaction test. Subsequently, in the current study we prepared a specific CRF1 receptor antagonist (N-Cyclopropylmethyl-2,5-dimethyl-N-propyl-N′-(2,4,6-trichloro-phenyl)- pyrimidine-4,6-diamine, NBI3b1996) to examine in this paradigm. This CRF1 receptor antagonist inhibited the ex vivo binding of 125I-sauvagine to rat cerebellum with an ED50 of 6 mg/kg, i.p. NBI3b1996 produced a dose-dependent antagonism of Urocortin-induced anxiety-like behavior in Social Interaction test with an ED50 of 6 mg/kg, i.p. The compound had no effect on baseline social interaction. In addition, the CRF1 receptor antagonist prevented the stress-induced decrease in social interaction. These results provide further support for the CRF1 receptor in anxiety-like behavior and suggest this pathway is quiescent in unstressed animals.

KW - (Rat)

KW - Amygdala

KW - Antagonist

KW - Behavior

KW - Corticotropin releasing factor

KW - Stress

UR - http://www.scopus.com/inward/record.url?scp=14144255303&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14144255303&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2004.12.030

DO - 10.1016/j.ejphar.2004.12.030

M3 - Article

C2 - 15733549

AN - SCOPUS:14144255303

VL - 509

SP - 145

EP - 153

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2-3

ER -